Edition:
United States

Antares Pharma Inc (ATRS.OQ)

ATRS.OQ on NASDAQ Stock Exchange Capital Market

2.34USD
26 Apr 2018
Change (% chg)

$0.06 (+2.63%)
Prev Close
$2.28
Open
$2.28
Day's High
$2.38
Day's Low
$2.27
Volume
76,056
Avg. Vol
298,436
52-wk High
$4.09
52-wk Low
$1.59

Revenue & Earnings Per Share

 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 35.24 32.21
P/E High - Last 5 Yrs. -- 41.33 45.93
P/E Low - Last 5 Yrs. -- 21.23 24.67
Beta 0.28 0.75 0.79
Price to Sales (TTM) 178.58 7.54 7.12
Price to Book (MRQ) -- 15.41 4.90
Price to Tangible Book (MRQ) -- 24.95 6.48
Price to Cash Flow (TTM) -- 24.44 24.70
% Owned Institutions -- 4.16 2.29

Dividends

  Company industry sector
Dividend Yield -- 0.89 1.57
Dividend Yield - 5 Year Avg -- 1.13 0.77
Dividend 5 Year Growth Rate -- 17.49 4.07
Payout Ratio(TTM) -- 27.63 20.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -64.35 14.68 9.38
Sales (TTM) vs TTM 1 Yr. Ago -42.76 11.00 11.18
Sales - 5 Yr. Growth Rate -5.00 8.90 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -54.02 79.36 24.18
EPS (TTM) vs TTM 1 Yr. Ago -28.03 -- --
EPS - 5 Yr. Growth Rate -- 19.77 10.39
Capital Spending - 5 Yr. Growth Rate 36.90 9.71 10.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.14 2.44 2.53
Current Ratio (MRQ) 0.22 3.21 3.59
LT Debt to Equity (MRQ) -- 28.67 11.47
Total Debt to Equity (MRQ) -- 33.07 14.16
Interest Coverage (TTM) -149.72 16.59 30.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 17.36 58.01 54.23
Gross Margin - 5 Yr. Avg. 50.95 57.58 52.19
EBITD Margin (TTM) -153.74 -- --
EBITD - 5 Yr. Avg -110.22 23.00 15.91
Operating Margin (TTM) -244.46 19.12 3.78
Operating Margin - 5 Yr. Avg. -131.86 15.69 11.22
Pre-Tax Margin (TTM) -244.96 18.73 4.45
Pre-Tax Margin - 5 Yr. Avg. -125.55 15.85 11.53
Net Profit Margin (TTM) -244.96 14.51 1.07
Net Profit Margin - 5 Yr. Avg. -125.55 10.97 7.86
Effective Tax Rate (TTM) -- 21.06 31.76
Effective Tax Rate - 5 Yr. Avg. -- 28.78 24.25

Efficiency

  Company industry sector
Revenue/Employee (TTM) 51,223 29,436,130 790,924,504
Net Income/Employee (TTM) -125,474 3,734,402 92,823,068
Receivable Turnover (TTM) 10.46 4.90 5.51
Inventory Turnover (TTM) 3.58 3.01 3.47
Asset Turnover (TTM) 0.80 0.76 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -195.99 10.70 10.41
Return on Assets - 5 Yr. Avg. -60.29 8.94 11.41
Return on Investment (TTM) -- 14.18 13.05
Return on Investment - 5 Yr. Avg. -76.85 11.67 14.78
Return on Equity (TTM) -- 16.92 14.90
Return on Equity - 5 Yr. Avg. -79.39 14.14 16.12
  1 Year 3 Year 5 Year
Sales % -42.76 -18.76 -5.00
EPS (TTM) % -28.09 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Antares Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.